Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2015 Annual Meeting

By: via Benzinga
Peregrine Pharmaceuticals (Nasdaq: PPHM) (Nasdaq: PPHMP) today announced that two preclinical abstracts and one clinical translation ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.